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The Regulation of Anoikis: MEKK-1 Activation
Requires Cleavage by Caspases
Michael H. Cardone,* Guy S. Salvesen,* or inhibiting caspase activity (Frisch and Francis, 1994;
Boudreau et al., 1995; Frisch et al., 1996a). The mecha-Christian Widmann,² Gary Johnson,²
and Steven M. Frisch*³ nism of these regulators, other signaling components,
and how they fit together have yet to be established. In*The Burnham Institute
La Jolla, California 92037 particular, it is important to identify caspase substrates
(reviewed in Chinnaiyan and Dixit, 1996; Nagata, 1997)²Division of Basic Sciences
National Jewish Center for Immunology relevant to apoptosis.
Recently, we found that Jun N-terminal kinases (JNKs)and Respiratory Medicine and
Department of Pharmacology are activated in and promote anoikis (Frisch et al.,
1996a); a role for JNKs in certain other (Xia et al., 1995;University of Colorado Medical School
Denver, Colorado 80206 Verheij et al., 1996), but not all (Liu et al., 1996), apoptotic
responses has been reported as well. Interestingly,
caspases must be active for JNKs to respond to the
loss of cell±matrix contact (Frisch et al., 1996a). Simi-Summary
larly, FAS ligation induces JNK activity in a caspase-
dependent manner (Cahill et al., 1996). In the simplestCertain cell types undergo apoptosis when they lose
mechanism, this suggests that caspases proteolyticallyintegrin-mediated contacts with the extracellular ma-
activate some component of the JNK pathway.trix (ªanoikisº). The Jun N-terminal kinase (JNK) path-
To identify that component, we considered the follow-way is activated in and promotes anoikis. This activa-
ing. The kinase activity of the initiating kinases of thetion requires caspase activity. We presently report that
MAPK (ERK1,2) and JNK pathways, Raf-1 and MEKK,a DEVD motif±specific caspase that cleaves MEKK-1
respectively, are activated by experimental deletion ofspecifically is activated when cells lose matrix contact.
their N-terminal domains (Bruder et al., 1992; Minden etThis cleavage is required for the activation of the
al., 1994). The truncated form of this MEKK (now knownkinase activity. When overexpressed, the MEKK-1
as MEKK-1, due to the cloning of several homologs, ascleavage product stimulates apoptosis; the wild-type,
reviewed in Fanger et al. (1997) is cytotoxic (Lassignal-full-length MEKK-1 sensitizes cells to anoikis; and a
Johnson et al., 1996). Thus, we hypothesized thatcleavage-resistant mutant of MEKK-1 partially pro-
MEKK-1 is a caspase target that is cleaved during an-tects cells against anoikis. The cleavage-resistant or
oikis to remove an inhibitory N-terminal domain. Thiskinase-inactive mutants also prevent caspase-7 from
report presents evidence for this hypothesis, identifyingbeing activated completely. Thus, caspases can in-
the activation of MEKK-1 as one mechanism by whichduce apoptosis by activating MEKK-1, which in turn




A Role for MEKK-1 in Anoikis
Epithelial cells (Frisch and Francis, 1994), endothelial and Inhibition by CrmA
cells (Meredith et al., 1993), muscle cells (Vachon et al., We first tested the role of MEKKs in anoikis, focusing
1996), and perhaps others undergo apoptosis when they on MEKK-1 due to its possible involvement in apoptosis
lose contact with extracellular matrix or bind through (Xia et al., 1995; Fanger et al., 1997). A kinase-inactive
an inappropriate integrin. This phenomenon, which has point mutant of MEKK-1 (MEKK-dn), which is a domi-
been termed ªanoikisº (the Greek word for ªhome- nant-negative with respect to JNK activation (Minden et
lessnessº), prevents shed epithelial cells from colonizing al., 1994), was expressed in Madin±Darby Canine Kidney
elsewhere, thus protecting against neoplasia (reviewed (MDCK) cells by retrovirus transduction. As expected,
in Ruoslahti and Reed, 1994). It is also an important MEKK-dn attenuated the JNK activation that was trig-
mechanism in the initial cavitation step of embryonic gered by cell±matrix detachment (Figure 1A). Although
development (Coucouvanis and Martin, 1995) and in this effect was small (z2-fold)Ðperhaps because the
mammary gland involution (Boudreau et al., 1995) and MEKK-dn stable expression level was lower than in the
has been exploited to prevent tumor angiogenesis previously reported transient transfection experiments
(Brooks et al., 1994). Thus, elucidating the mechanism (Minden et al., 1994)Ðanoikis was substantially sup-
of anoikis will be important in understanding a diversity pressed (Figure 1B). To quantitate this suppression,
of normal and pathologic phenomena. cells that had been transiently transfected with an HA
Epithelial cells could become resistant to anoikis by epitope±tagged MEKK-dn expression construct were
activating integrin signaling, as we have shown pre- suspended and doubly stained for HA epitope and
viously for focal adhesion kinase (Frisch et al., 1996b). nuclear morphology (DAPI; Figure 1C). Among the con-
Anoikis resistance can also arise from the loss of apo- trol cells, 16.5% displayed apoptotic nuclei after three
ptotic signaling, for example, by overexpressing Bcl-2 hours of suspension, while only 1.7% of the MEKK-dn-
expressing cells were apoptotic by this criterion; MEKK-
dn provided similar anoikis resistance at 24 hours of³To whom correspondence should be addressed.
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Figure 1. Dominant-Negative MEKK-1 Inhib-
its Anoikis
Dominant-negative MEKK-1 was expressed
in MDCK cells by retroviral transduction using
the construct described in Experimental Pro-
cedures. For brevity, results for one represen-
tative cell line are shown.
(A) Effect of the dominant-negative MEKK-1
on JNK activity. Control (Con) or dominant-
negative (dn) MEKK-expressing cells were
assayed for JNK activity under attached (att)
or 30 min±suspended (sus) conditions.
(B) Effect of the dominant-negative MEKK-1
on anoikis (DNA cleavage assay). Cells were
suspended for 3 hr prior to analysis of low
molecular weight DNA on an agarose gel as
described previously (Frisch and Francis,
1994).
(C) Effect of the dominant-negative MEKK-1
on anoikis (nuclear morphology assay). Cells
that had been transiently transfected with
MEKK-dn were suspended for 3 hr and dou-
bly stained for the HA epitope on the
transgene and for nuclear morphology using
DAPI. The fractions of apoptotic nuclei
among the HA-positive and HA-negative cells
were scored and are indicated beneath pho-
tographs of one representative field.
suspension (Figure 6 below), indicating that it reduced kDa, a hyperphosphorylated form (Figure 3A). A car-
boxy-terminal z80 kDa cleavage product was observedthe fraction of cells undergoing apoptosis. Thus, MEKK-1
was apparently involved in anoikis. to increase significantly after suspension of the cells.
The cleavage product in the ªattachedº sample aroseWe then assayed the effect of cell±matrix interactions
on MEKK-1 activity. Suspension of MDCKcells in growth from spontaneously apoptotic cells present in these
cultures (Frisch and Francis, 1994). It was found at amedium stimulated thekinase activityof MEKK-1 (Figure
2A), as measured by an immune-complex kinase assay. much lower level in cells that expressed the CrmA pro-
tein, even after cell suspension. Cytoplasmic extractsThis stimulation could be reversed by replating cells that
had been in suspension for thirty minutes (Figure 2B). from suspended MDCK cells cleaved in vitro-translated
MEKK-1 to yield fragments of z78 kDa and z100 kDaThus, cell±matrix interactions regulated MEKK-1 ac-
tivity. (Figure 3A); only the z78 kDa fragment could be immu-
noprecipitated by the carboxy-terminal-specific anti-Previously, we found that the activation of JNKs by
cell suspension was CrmA inhibitable, suggesting a role body (data not shown). By contrast, extracts from
attached MDCK cells or suspended, CrmA-expressingfor the caspases in this activation (Frisch et al., 1996a).
To test whetherMEKK-1 activation was CrmA inhibitable or Bcl-2-overexpressing MDCK cells did not carry out
this cleavage (Figure 3A).as well, we assayed MEKK-1 extracted from MDCK cells
that stably expressed CrmA protein. CrmA substantially Interestingly, purified recombinant caspase-3, -7,
and -8 yielded the same cleavage product as the apo-suppressed the activation of MEKK-1 (Figure 2A). Sus-
pension of the cells also induced autophosphorylation ptotic extracts (Figure 3A). While caspase-3 and -8
yielded both the z78 kDa and intermediate-sized prod-(Figure 2C) of both the full-length MEKK-1 protein and
a cleavage product of z80 kDa (that is further discussed ucts, an equal amount of caspase-7 activity generated
only the z78 kDa product, suggesting that the latter isbelow); CrmA suppressed autophosphorylation as well.
These results suggested that MEKK-1, or some com- the most potent MEKK protease of those tested.
The combined results suggested that the apoptoticponent upstream of it, required a caspase for its acti-
vation. extracts contained the activated form of a caspase that
cleaved MEKK-1. To confirm this, apoptotic extracts
were preincubated with various concentrations of theMEKK Is Specifically Cleaved by Caspases
during Anoikis caspase-inhibitor peptides, Ac-DEVD-CHO or Ac-YVAD-
CHO, and then assayed for MEKK cleavage activity. ThisTo explore the possibility that caspase-mediated cleav-
age contributed to the activation of MEKK-1, we tested cleavage activity was extremely sensitive to inhibition
by the Ac-DEVD-CHO peptide but less sensitive to inhi-the cleavage of MEKK-1 in vivo and in vitro. The full-
length MEKK-1 was found in both attached and sus- bition by the Ac-YVAD-CHO peptide (Figure 3B), con-
firmingthat theproteolytic activity was due toa caspase,pended MDCK cells as a series of bands ranging from
z160 kDaÐthe predicted molecular weightÐto z200 specifically one that recognizes DEVD motifs.
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protein was tested for susceptibility to cleavage by
apoptotic cell extract or caspase-3. The mutant was
cleavage resistant (Figure 4), confirming the identity of
the cleavage sites.
MEKK-1 Activation Requires Cleavage
CrmA inhibited both the activation of MEKK-1 and
MEKK-1's cleavage after cell±matrix disruption. These
results suggested that the cleavage might activate the
kinase activity of MEKK-1.
To test this possibility, the wild-type or cleavage-
resistant (D871 and D874 mutated to glutamates) forms of
MEKK-1 were C-terminally tagged with HA epitope and
expressed in MDCK cells (Figure 5A). Far less wild-type
MEKK-1 protein was expressed than cleavage-resistant
MEKK-1. This possibly reflected a deletion of the wild-
type-positive cells by apoptosis or an extreme instability
of the wild-type protein, or both. Most or all of the ex-
pressed wild-type protein was z80 kDa. In contrast, the
mutant form retained its full length (z196 kDa). Kinase
assays indicated that the transfected wild-type protein
was about 30-fold more active than the cleavage-resis-
tant protein, despite the much higher expression of the
latter. Thus, the specific activity of the wild type was
approximately 500-fold higher than that of the cleavage-
resistant enzyme, based on a comparison of shorter
exposures of the Western blot (data not shown). The
cleavage and activation of the wild-type protein was
independent of an apoptotic stimulus. We assume that
the overexpressed wild-type protein was spontaneously
cleaved at a low level, inducing an apoptotic pathway
that resulted in more cleavage/activation, creating a
positive feedback loop (c.f., Figure 6 below and Wid-
mann et al., submitted). In any event, these results con-
firmed that the cleavage of MEKK-1 by caspases was
Figure 2. The Loss of Cell±Matrix Contact Induces MEKK-1 Activity, required for activation of the enzyme.
Which Is Blocked by CrmA
To test this by a different approach, the endogenous
(A) Induction of kinase activity. Control MDCK cells (M) or CrmA-
MEKK-1 was immunoprecipitated from attached MDCKexpressing MDCK cells (C) described previously (Frisch et al., 1996a)
cells, cleaved with caspase-7 under conditions knownunder attached (att) or suspended conditions (sus. 30 min, sus.
to cleave all of the enzyme, and assayed. This cleavage120 min) were assayed for kinase activity on kinase-inactive MEK-1
substrate as described in Experimental Procedures. substantially activated MEKK-1 (Figure 5B).
(B) Reversal of kinase activation by reattachment. Cells were sus-
pended for 30 min and then reattached to collagen-coated dishes;
at the indicated times, lysates were prepared and equal amounts The Role of MEKK-1 Cleavage in Anoikisof protein were assayed for MEKK-1 activity.
The results above suggested that product generated by(C) Induction of autophosphorylation. Cell lines treated as in (A)
caspase cleavage of MEKK might mediate apoptosis,were assayed for autophosphorylation, except that the substrate
protein was omitted. Results of phosphorimager scans of the phos- especially in light of the partial inhibition of anoikis by
phorylated full-length product (z196 kDa) and cleaved product (z90 dominant-negative forms of JNKK (Frisch et al., 1996a)
kDa) are shown. or MEKK-1 (above).
To test this possibility, we transfected an expression
construct containing the caspase cleavage product ofIdentification of the Cleavage Sites
To identify the cleavage site, the in vitro-translated MEKK-1 (amino acids 875±1493), which was epitope
tagged. As a control, a kinase-inactive mutant of thisMEKK-1 protein was cleaved with apoptotic MDCK cell
extract or caspase-3 and subjected to radiolabeled se- protein was expressed similarly. A total of 50 epitope-
positive cells were scored for apoptosis by viewing thequencing (see Experimental Procedures). The cleavage
product was an approximately equal mixture of two morphology of DAPI-stained nuclei. All 50 of the cells
transfected with the kinase-active cleavage productpolypeptides having two closely spaced N termini. One
N terminus was T872, which is adjacent to the se- were apoptotic. By contrast, none of 50 cells expressing
the kinase-inactive form were apoptotic (see Figure 6Aquence 868GVED871; the other was G875, lying adjacent to
871DTVD874. Both cleavages are compatible with DEVD for representative immunofluorescence results). This
demonstrated that the MEKK-1 cleavage product is pro-motif±specific caspases such as caspase-3 or -7.
To confirm the cleavage site assignment, both D871 apoptotic and was consistent with the behavior of a
non±naturally occurring MEKK-1 protein (amino acidsand D874 were mutated to glutamates, and the resulting
Cell
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Figure 3. The Loss of Cell±Matrix Contact In-
duces a Proteolytic Activity That Cleaves
MEKK-1
(A) Cells undergoing anoikis contain a site-
specific MEKK-1 protease that resembles a
caspase. (in vivo): Lysates were prepared
from MDCK (M) or CrmA/MDCK (C) cells under
attached (att) or 2 hr±suspended conditions
(sus). These were analyzed on a Western blot
using an anti-MEKK-1 carboxy-terminal-spe-
cific antibody. A long autoradiographic expo-
sure of the Western blot (left panel) reveals
the series of bands corresponding to the full-
length product; a shorter exposure of the
same blot (right panel) reveals the increased
amount of cleavage product in the suspended
cells compared with attached cells (N.B.:
the small amount of cleavage product in the
attached cells is most likely due to contami-
nation by spontaneously apoptotic cells). (in
vitro): The right panel shows that the MEKK-1
cleavage activity is induced by the loss of
cell±matrix contact and inhibited by CrmA.
Cytoplasmic extracts from control MDCK
cells (M), CrmA-expressing MDCK cells (C), or
bcl-2-overexpressing (B) cells in the attached
(att) or suspended (sus) condition were as-
sayed for cleavage of in vitro-translated
MEKK-1 as described in Experimental Proce-
dures. The left panel shows that caspases
and MDCK cell lysates generate similar
MEKK-1 cleavage products. In vitro-trans-
lated MEKK-1 was cleaved with suspended-
cell lysates as in (A) or with the three cas-
pases indicated (in similar amounts), followed
by SDS±PAGE and autoradiography.
(B) The MEKK-1 cleavage activity in cells un-
dergoing anoikis is inhibited by a caspase-
specific inhibitor. Cytoplasmic extracts from
suspended MDCK cells were preincubated
with the indicated concentrations of DEVD
or YVAD peptides and then mixed with full-
length MEKK-1. The amounts of the z80 kDa
cleavage product were then quantitated to
calculate the percentage by which cleavage
was inhibited.
1178±1493) that was previously tested in 3T3 cells (Las- frequency of apoptosis, rather than simply retarding the
rate of apoptosis. Moreover, DE-expressing cells thatsignal-Johnson et al., 1996).
To compare the effects of the wild-type and cleavage- were replated after 24 hours of suspension were capable
of spreading (data not shown), indicating viability. Theseresistant forms of MEKK-1 on anoikis, both forms were
transfected into MDCK cells (as HA-tagged proteins). results confirm that the caspase-generated MEKK-1
fragment suffices to induce apoptosis and that MEKK-1After allowing one day for expression of the proteins
and growth to confluence, the cells were suspended (wild-type) sensitizes and MEKK-1 (cleavage-resistant)
desensitizes cells to anoikis. Thus, the cleavage ofand doubly stained for HA and nuclear morphology
(DAPI). The HA-positive and HA-negative cells were then MEKK-1 is involved in anoikis.
scored for anoikis by fluorescence microscopy. About
90% of the cells expressing the wild-type MEKK-1 pro-
tein were apoptotic even prior to being suspended, and, Control of Caspase Activation by MEKK-1
The inhibition of anoikis by MEKK-1 dominant-negativesbecause this protein was rapidlydegraded insuspended
cells, these cells could not be assayed in this fashion; suggested two possibilities: (1) the suppression of
MEKK signaling allowed MDCK cells to survive despitehowever, this clearly indicated the potent proapoptotic
activity of the wild-type protein. By contrast, the cleav- having active caspases, or (2) the suppression of MEKK
signaling blocked the activation of caspases.age-resistant mutant did not cause apoptosis. In fact,
after suspension, the cells bearing this mutant under- To distinguish between these possibilities, cells trans-
fected with cleavage-resistant or MEKK-dn mutants inwent anoikis about one-fourth as frequently as control
cells (Figure 6B), indicating a dominant-negative effect. an episomal vector that confers hygromycin resistance
were selected in hygromycin for five days. After selec-An anoikis time course performed over 24 hours indi-
cated that the dominant-negatives reduced the ultimate tion, the cells transfected with the wild-type MEKK-1
Caspases Activate MEKK-1 for Apoptosis
319
Figure 4. Identification of the Caspase Cleavage Site in MEKK-1
The two aspartic acid residues at which caspase-3, or caspase-7
or apoptotic MDCK cell lysates cleave MEKK-1 were determined
by radiolabeled sequencing as described in Experimental Proce-
dures and are identified above; all three proteases generated the
same cleavage sites. To confirm this identification, both aspartates
were mutated to glumates to produce the mutant substrate (DE). In
vitro-translated wild-type (wt) or DE proteins were challenged with
caspase-7, apoptotic extract from suspended MDCK cells (sus), or
control MDCK lysate (att) as indicated, and the cleavage products
were detected by autoradiography.
expression construct were epitope negative, presum-
ably due to apoptosis, while 70%±90% of the cells
transfected with the mutants were epitope positive (data
not shown).
The drug-resistant cells of each type were then sus-
pended and assayed for the appearance of the 20 kDa Figure 5. Caspase-Mediated Cleavage Is Required for Activation of
active subunit of caspase-7. Interestingly, cellsexpress- MEKK-1 Kinase Activity during Anoikis
ing either cleavage-resistant MEKK-1 or MEKK-dn con- (A) Mutation of the cleavage sites inhibits activation. MDCK cells
tained far less caspase-7 p20 subunit than control cells were electroporated with equal amounts of expression vectors en-
coding the wild-type (wt) or in vitro cleavage-resistant (DE) mutant(Figure 7A).This indicated that inhibition of MEKK signal-
MEKK-1 proteins. One sample of transfected cells was analyzed foring suppressed the proteolytic events known to be re-
expression of the proteins on a Western blot, using an antibody thatquired for the activation of caspase-7.
recognizes the HA epitope tag. Another sample was assayed for
As shown above (Figure 5A), transiently overex- MEKK-1 kinase activity.
pressed MEKK-1 was cleavedspontaneously to the z80 (B) Cleavage with caspase-7 activates MEKK-1. MEKK-1 was immu-
kDa form. Because this cleavage was carried out by noprecipitated from attached (att) or suspended (sus) MDCK cells.
It was then treated with the indicated amounts of caspase-7 andcaspases, this suggested that the high concentration
assayed for MEKK-1 activity on MEK-1 substrate as described inof MEKK-1 might have initiated an apoptotic positive
the Experimental Procedures.feedback loop, in which a small amount of caspase
activity cleaved MEKK-1, provoking MEKK-1 to activate
MEKK-1 requires caspase-mediated proteolysis, gener-more caspase activity. If this were thecase, then overex-
ating a fragment that promotes anoikis and further cas-pression of the full-length MEKK bearing a mutation of
pase activation. While MEKK-1 requires cleavage bythe catalytic domain would fail to trigger the feedback
caspases for activation, additional events such as auto-loop and would be resistant to this spontaneous cleav-
phosphorylation may also be required. Indeed, exten-age. To test this hypothesis, MEKK-1 (full-length wild-
sive autophosphorylation is observed following antype) or MEKK-1 (full-length K1257M) were transfected
apoptotic stimulus, and phosphatase treatment hasinto MDCK cells. Western blot analysis performed on
been shown to inhibit the enzyme (Widmann et al., sub-cells one day posttransfection revealed that the kinase-
mitted). Nevertheless, these results show that caspasesinactive MEKK-1 was indeed resistant to spontaneous
participate in the activation of MEKK-1.cleavage (Figure 7B); it had failed to activate caspases.
The cleavage/activation of MEKK-1 appeared to beA positive feedback loop involving caspases and
critical for anoikis by several criteria. First, MEKK-1 thatMEKK-1 is indicated.
was activated by deletion of the N-terminal domain
was potently apoptotic. Secondly, a cleavage-resistant
Discussion MEKK-1 mutant substantially protected cells against
anoikis (which is usually assayed at 3 hours) for at least
Previously, we reported the phenomenon of anoikis 24 hours. In principle, the mutant could act as a domi-
(Frisch and Francis, 1994) and demonstrated that the nant-negative by interfering with molecules positioned
sequence of information flow is: integrins→Bcl-2/Bax→ either upstream or downstream of MEKK-1 in the signal-
(caspases↔JNK)→apoptosis (Frisch et al., 1996a). In ing pathway. To signal in the pheromone response path-
way, the budding yeast homolog of MEKK, STE11, mustthe present study, we have found that the activation of
Cell
320
Figure 6. Caspase Cleavage of MEKK Is In-
volved in Anoikis
(A) The MEKK-1 cleavage product induces
apoptosis. Expression vectors containing the
AU1 epitope±tagged MEKK-1 cleavage prod-
uct (amino acids 874±1493) in kinase-active
or kinase-inactive (K1257M) forms were elec-
troporated into MDCK cells. Thirty-eight
hours later, cells were fixed and doubly
stained anti-AU1 antibody (plus FITC-labeled
secondary antibody) and with DAPI. The frac-
tion of AU1-positive cells that were apoptotic
was counted. A representative cell of each
type is shown.
(B) Cleavage-resistant MEKK-1 protects
against anoikis. Cells were transfected with
pCEP4 vector (V), cleavage-resistant MEKK-1
(DE), or MEKK-dn (dn). Twenty-four hours
later, cells were suspended for three hours
and doubly stained for the HA epitope tag
on the MEKK-1 transgene (or for the EBNA-1
antigen encoded by the pCEP4 vector) and
with DAPI. Apoptotic cells, indicated by nu-
clear morphology, were scored among the
epitope-positive and epitope-negative popu-
lations, and the calculated apoptotic frequen-
cies are indicated. (The wild-type MEKK-1
protein induced apoptosis prior to cell sus-
pension and was not scored in this assay;
see text.)
bind a scaffolding protein, STE5; kinase-mutated STE11 signaling through the MEKK-JNKK-(JNK, other sub-
strates) module regulates caspase activation. Thus, thecan saturate the STE5 binding sites and exclude the
endogenous, kinase-active STE11 from the signaling kinase-inactive mutants, generated by mutations in ei-
ther the catalytic domain or the cleavage site, most likelycomplex (reviewed in Herskowitz, 1995). The kinase-
mutated or cleavage-resistant MEKK-1mutants may be- block anoikis by excluding the endogenous MEKK-1
from a signaling complex, thus inhibiting the function ofhave similarly. Competetive inhibition of caspases by
the MEKK-1 mutants is very unlikely, by the following the signaling module (Herskowitz, 1995). One conse-
quence is that effector caspases fail to become acti-analogy: peptides corresponding the caspase-cleavage
site of PARP competitively inhibit ªPrICEº (caspase-3) vated, interrupting a positive feedback loop involving
MEKK-1 and caspases.activity, but uncleavable mutant peptides fail to inhibit
the enzyme (Lazebnik et al., 1994). Nevertheless, the Certain other protein kinases relevant to apoptosis
are activated by proteolysis. For example, PITSLRE, acleavage-resistant MEKK-1 inhibited the activation of
caspase-7 while inhibiting anoikis, acting, in this sense, member of the Cdk family, is activated by serine prote-
ases to mediate FAS-induced apoptosis in T cells (Lahtias an inhibitor of the caspase proteolytic cascade. Pre-
viously, we reported that a dominant-negative mutant et al., 1995). In addition, caspase-3 cleaves protein ki-
nase C-d to generate an active fragment that stimulatesof JNKK also inhibited the activation of caspase-7
(Frisch et al., 1996a). The combined results suggest that the JNK pathway and apoptosis (Emoto et al., 1995).
Caspases Activate MEKK-1 for Apoptosis
321
It will be important to learn how cell±matrix interac-
tions regulate the caspases and MEKK-1. In this connec-
tion, mammary epithelial cells destined to undergo an-
oikis have elevated ICE (caspase-1) expression levels
(Boudreau et al., 1995), which could perhaps cause in-
creases in effector caspases such as caspase-7. An-
other potential mode of regulation involves the Bcl-2/
Bax family of apoptotic proteins that can modulate cas-
pase activity (Chinnaiyan et al., 1996; Frisch et al.,
1996a), possibly by interaction through homologs of the
C. elegans Ced-4 protein (Chinnaiyan et al., 1997). The
levels of Bcl-2 protein may in turn be modulated by
integrins (Zhang et al., 1995) or cell±cell interactions
(Frisch et al., 1996a).
Experimental Procedures
Plasmids and Gene Transfer
The full-length MEKK-1 cDNA clone in bluescript was kindly pro-
Figure 7. Activation of Caspases by MEKK-1: Evidence for a Posi- vided by Gary Johnson. Substitution of D872 and D874 by gluta-
tive Feedback Loop mates was performed by PCR-directed mutagenesis. Carboxy-ter-
(A) MEKK-1 affects the activation of caspase-7. MDCK cells were minal HA tags were added by PCR, and both wild-type and mutant
transfected with vector alone (Vec), wild-type MEKK-1 (wt), cleav- forms were subcloned into pCEP4.
age-resistant MEKK-1 (DE), or MEKK-dn (dn). Western blots of the To create the MEKK-1 dominant-negative expression construct,
attached (att) cells were analyzed for caspase-7 p20 subunit 2 days the BglII±Nhe 1 fragment from the wild-type clone was replaced
after transfection. Transfected cells were also selected in hygro- with the corresponding fragment from the kinase-dead (K1257M)
mycin for 5 days, yielding cell populations that were 70%±90% clone. The Nco±SspI fragment containing amino acids 1178±1493
positive for the transgene (except in the case of the wild-type gene, was subcloned into BamHI,SnaBI-cut pBABE vector using a 59
where 0% of the cells were positive). These mixed populations were BamHI-AUI epitope-Nco oligonucleotide. Retroviruses were pack-
suspended for 2 hr and lysates were analyzed for p20. aged and used to generate stable cell lines as described previously
(B) The kinase activity of overexpressed MEKK-1 is required for (Frisch et al., 1996a).
spontaneous cleavage in vivo. Cells transfected with MEKK-1 (full- Truncated versions of the full-length wild-type and the K-to-M
length) or MEKK-1 (full-length K1257M) were analyzed 24 hr later mutant starting from the cleavage sites were cloned into EcoRI,
by Western blotting with HA epitope±specific antibodies. NotI cut pCep4. These clones were tagged with the AU1 epitope at
the amino terminus. They were then subcloned into pTracer (In-
Vitrogen) for expression studies following electroporation of 150 mg
Thus, the proteolytic activation of protein kinases may into MDCK cells (300 V, 450 mF; unpublished protocol developed
prove important in several aspects of apoptosis. by Hiro Kai, Kumamoto University, and Curtis Okamoto, University of
Southern California). Cells were analyzed 36 hr after electroporation.Determining which substrates of MEKK-1 are relevant
to anoikis or other forms of apoptosis will be an interest-
Radiolabeled Sequencinging challenge. The activation of JNKK (and in turn JNK)
Radiolabeled sequencing was performed as described previouslyby MEKKs (Minden et al., 1994) would appear to be
(Salvesen and Engchild, 1990). Briefly, full-length MEKK-1 in pBlue-
relevant, because JNK activity is required for optimal script was transcribed with T3 polymerase and translated using the
anoikis of MDCK cells (Frisch et al., 1996a). Recently, a TNT system (Promega); it was labeled with either 35S-methionine or
major substrate for phosphorylation by JNK, c-Jun, was 3H-leucine. The translation reaction was fractionated on SDS±PAGE
and electroblotted onto a PVDF membrane. After autoradiography,shown to promote apoptosis in one particular system
the position of the 35S-methionine-labeled MEKK-1 band was used(Bossy-Wetzel et al., 1997). The role of the JNK pathway
as a guide to excise a filter piece containing the 3H-leucine-labeledin other apoptotic contexts is variable, however. For
band. This was then subjected to automated sequencing, and the
example, the blockage of JNK activity using dominant- products of each cycle were counted in a scintillation counter. Com-
negative JNKK inhibits apoptosis of PC12 cells in re- parison of the known positions of leucines relative to aspartates
sponse to NGF withdrawal (Xia et al., 1995) or of fibro- (because the cleavage was carried out by a caspase) with the cycle
numbers where radioactive peaks were found allowed thedeductionblasts in response to ceramide (Verheij et al., 1996).
of the cleavage sites.By contrast, TNF-a-induced apoptosis of HeLa cells is
resistant to inhibition of the JNK pathway (Liu et al.,
Antibodies1996). These experiments are difficult to compare, be-
Anti-MEKK-1 C-terminal antibody was from Santa Cruz Biotech
cause short-term DNA fragmentation assays were used (Santa Cruz, CA). Anti-AU1 epitope antibody was from Babco
in some and longer-term cell viability assays in others. (Berkeley, CA). Anti-HA epitope antibody (12CA5) was from Boeh-
In fact, the apparent discrepancies could be resolved ringer-Mannheim.
by concluding that blockage of the JNK pathway can
delay but not permanently prevent apoptosis, and such Kinase Assays
Confluent monolayers of MDCK cells trypsinized, and either lyseda delay might still be compatible with the notion that JNK
immediately or suspended in complete medium at 378C for the indi-is involved in apoptosis. Another potentially relevant
cated times. Lysates (0.4 ml per confluent 100 mm dish) were madesubstrate is the IkBa kinase, which, when phosphory-
in either JEB (25 mM HEPES [pH 7.7], 0.3 mM NaCl, 1.5 mM MgCl2,
lated by MEKK-1, activates the degradation of IkBa and 0.1% Triton X-100, 20 mM b-glycerophosphate, 0.1 mM sodium
the activation of NF-kB (Lee et al., 1997); NF-kB affects vanadate) or MEKK-EB (Blank et al., 1996; 20 mM HEPES [pH 7.6],
1% Triton X-100, 0.5% NP-40, 150 mM NaCl, 20 mM sodium fluoride,apoptosis context-specifically (Gilmore et al., 1996).
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2 mM sodium vanadate) containing 10 mg/ml of aprotinin, 10 mg/ml The caspases were obtained predominantly as the active two-
chain forms, with yields of 0.5±1.0 mg/L of induced culture and wereof leupeptin and 0.5 mM PMSF. MEKK was immunoprecipitated by
incubation with 2±3 mg of anti-MEKK antibody for 2 hr at 48C, fol- judged to be more than 95% pure by SDS±PAGE and N-terminal
sequence analysis. Protein concentrations were determined by ab-lowed by the addition of 25 ml of a 50% slurry of g-bind (Pharmacia)
and incubation for an additional 45 minutes with rotation. Immune sorbance at 280 nm (Edeloch, 1967).
complexes were washed twice in lysis buffer, twice in PAN (10 mM
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